Nautilus Biotechnology
Keith Bjornson is a highly experienced scientist with a strong focus on enzyme research, assay development, and protein purification. Currently serving as a Principal Scientist at Nautilus Biotechnology since September 2024, Bjornson has held progressively senior roles, including Research Fellow at Ansa Biotechnologies, Inc. and Principal Scientist at both Pacific Biosciences and 10X Technologies. Bjornson's earlier career includes positions as Staff Scientist and manager at Applied Biosystems, Scientist II at CEPTYR, Inc., and Research Associate at Duke University Medical Center. Bjornson earned a Doctor of Philosophy in Biophysics from Washington University in St. Louis and a Bachelor of Arts in Chemistry from the University of Oregon.
This person is not in any teams
Nautilus Biotechnology
Nautilus (Nasdaq: NAUT) is a company with a vision to revolutionize biomedicine by unlocking the complexity of the human proteome. They are driven to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across biomedical research and drug discovery.